July 1, 2020

ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital

Billerica, MA, July 1, 2020: ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint venture of Harvard University, Massachusetts… Read more »

January 4, 2019

ProterixBio, Inc. presenting at Biotech Showcase™ 2019

  ProterixBio, Inc. will be attending Biotech Showcase™ 2019, to be held January 7-9th at the Hilton San Francisco Union Square. Biotech Showcase™, along with the Digital Medicine and Medtech Showcase, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and… Read more »

November 1, 2018

November is COPD Awareness Month

ProterixBio is transforming chronic disease management through novel bioclinical analytics and digital health technologies. Our first area of focus is COPD. Join us this November to spread awareness about this chronic disease. Imagine breathing through a straw – that’s what it feels like to live with COPD. Every four minutes, someone dies of chronic obstructive… Read more »